API Gallery
The global Pirtobrutinib market is projected to grow at a CAGR of 7.1% during the forecast period, driven by its breakthrough role in the treatment of relapsed or refractory B-cell malignancies, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).
The global Prochlorperazine market is projected to grow at a CAGR of 4.7% during the forecast period, driven by its consistent application in managing severe nausea and vomiting, vestibular disturbances, and schizophrenia-related symptoms.
The global Pyrimethamine market is projected to grow at a CAGR of 5.4% during the forecast period, driven by its well-established use in the treatment of protozoal infections, especially toxoplasmosis and malaria.
The global Pyrithione Zinc market is projected to grow at a CAGR of 5.2% during the forecast period, driven by its widespread use as an antifungal and antibacterial agent in personal care products.
Sulfiram market is experiencing a CAGR of 6.4% during the forecast period, Sulfiram is an antiparasitic agent used primarily for the treatment of scabies and lice.
The global Pyrroloquinoline Quinone market is projected to grow at a CAGR of 7.3% during the forecast period, driven by its rising application in cognitive enhancement, mitochondrial health support, and anti-aging supplements.
The global Quercetin market is projected to grow at a CAGR of 6.1% during the forecast period, driven by its expanding application in antioxidant therapy, immune support, allergy relief, and cardiovascular health.
Sulfobutylether-β-Cydodextrin (SBECD) market is experiencing a CAGR of 7.1% during the forecast period, driven by rising demand for advanced drug delivery systems and solubilizing agents.
The global Quetiapine Hemifumarate market is projected to grow at a CAGR of 5.6% during the forecast period, driven by its widespread use in the treatment of psychiatric disorders including schizophrenia, bipolar disorder, and major depressive disorder.
Sulpiride market is experiencing a CAGR of 6.2% during the forecast period. The market is driven by rising global awareness of mental health conditions and an increasing prevalence of psychiatric disorders such as schizophrenia and major depressive disorder.
The global Quinapril market is projected to grow at a CAGR of 3.8% during the forecast period, driven by its consistent application in the treatment of hypertension and congestive heart failure.
Sumatriptan market is experiencing a CAGR of 5.5% during the forecast period, driven by the rising prevalence of migraine disorders and the growing preference for affordable generic treatments.
Sugammadex Sodium market is experiencing a CAGR of 7.2% during the forecast period, driven by its increasing End-Users across pharmaceuticals, food & beverages, and cosmetics industries.
The global Quinfamide market is projected to grow at a CAGR of 4.7% during the forecast period, driven by its established role in the treatment of intestinal parasitic infections, especially amoebiasis.
Sulbactam market is experiencing a CAGR of 7.3% during the forecast period. The market growth is driven by the rising demand for combination antibiotics, particularly for treating β-lactamase-producing bacterial infections.
Search from 10,000 + API reports
How can we help you?
Reach out to discuss how our team can help your business achieve real results.
